Eczema drug safety in pregnancy under scrutiny
NCT ID NCT05721937
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This study watches pregnant women with eczema who take the drug CIBINQO and compares them to those who don't, to see if the drug affects the baby. About 400 women will join, and their babies will be followed for 12 months after birth. No extra treatments are given—just routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer
RECRUITINGNew York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.